{
  "case_id": "case_0052",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 58.08,
    "sex": "Male",
    "genderIdentity": "Cisgender Female",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve.",
      "structured_data": {
        "gt_lesions_english": [
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- Compressive Optic Neuropathy, NAION, Central Retinal Vein Occlusion, Central Retinal Artery Occlusion and Giant Cell Arteritis.\n\nOther possible differentials:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, SLE, Neurosyphilis, Bartonella and Retinal Detachment.\n- Also feasible but of low probability: TB, Beh\u00e7et's, Lyme, Lymphoma, Vasculitis, Sjogren's and Leber's Hereditary Optic Neuropathy.",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Arteritic anterior ischaemic optic neuropathy due to giant cell arteritis",
          "Non-arteritic anterior ischaemic optic neuropathy",
          "Demyelinating optic neuritis (including multiple sclerosis associated optic neuritis)",
          "Central retinal artery occlusion",
          "Central retinal vein occlusion",
          "Compressive optic neuropathy (for example optic nerve sheath meningioma or orbital mass)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "Compressive_Optic_Neuropathy",
          "Ischemic_Optic_Neuropathy_NAION",
          "Central_Retinal_Vein_Occlusion",
          "MS",
          "Central_Retinal_Artery_Occlusion",
          "Giant_Cell_Arteritis"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "Bartonella_Henselae",
          "Idiopathic_Optic_Neuritis",
          "Behcet_Disease",
          "Infection_Lyme",
          "Retinal_Detachment",
          "Syphilis",
          "CNS_Lymphoma",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "CNS_Vasculitis",
          "Autoimmune_Myelitis_Sjogren",
          "Autoimmune_Myelitis_SLE",
          "Optic_Neuropathy_Nonspecific",
          "Leber_Hereditary_Optic_Neuropathy",
          "MOGAD"
        ],
        "missing_common_names": [
          "Bartonella",
          "Retinal Detachment",
          "Neurosyphilis",
          "NMOSD (AQP4+)",
          "Neurosarcoid",
          "SLE",
          "MOGAD"
        ],
        "missing_low_prob_names": [
          "TB",
          "Beh\u00e7et's",
          "Lyme",
          "Lymphoma",
          "Vasculitis",
          "Sjogren's",
          "Leber's Hereditary Optic Neuropathy"
        ],
        "additional_diagnoses": []
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 0,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 22,
        "lesion_ddx_matched_count": 6,
        "lesion_ddx_missed_common_count": 7,
        "lesion_ddx_missed_low_prob_count": 7,
        "lesion_ddx_coverage_percentage": 0.2727272727272727
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Orbits and Brain - would potentially inform a diagnosis/details of multiple sclerosis.\n\nBut incomplete, should also consider: CSF test for Oligoclonal Bands.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: ANA, CRP, ENA, ACE, ANCA, syphilis, ESR, lyme.\n- Could also consider testing: anti-dsDNA, anti-MOG, bartonella, TB, HIV, anti-AQP4, CSF (flow cytometry and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "Urgent ophthalmology assessment with dilated fundus examination",
          "Erythrocyte sedimentation rate",
          "C-reactive protein",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "Blood glucose",
          "Temporal artery ultrasound",
          "Temporal artery biopsy",
          "MRI of orbits and brain with gadolinium contrast",
          "Visual field testing with automated perimetry",
          "Optical coherence tomography of retinal nerve fiber layer and macula",
          "Lipid profile",
          "Autoimmune screen including antinuclear antibodies and extractable nuclear antigen panel",
          "Antineutrophil cytoplasmic antibodies",
          "Serum angiotensin converting enzyme level",
          "Infectious screen including syphilis serology and Lyme serology if clinically indicated"
        ],
        "all_identified_ft_keys": [
          "Lipid_Profile",
          "CRP",
          "Autoimmune_Screen_General",
          "ENA_Panel",
          "LFT",
          "MRI_Orbits",
          "Serum_ACE",
          "Glucose_HbA1c",
          "U_and_E",
          "Temporal_Artery_Biopsy",
          "Syphilis_Serology",
          "Lyme_Serology",
          "FBC",
          "ANA",
          "OCT",
          "Ophthalmology Assessment",
          "ANCA",
          "MRI_Brain",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "ANA",
          "CRP",
          "MOG_Antibodies",
          "Bartonella_Serology",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "ANA",
          "CRP",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "missing_inv_keys_ddx": [
          "Anti_dsDNA",
          "CSF_Flow_Cytometry",
          "MOG_Antibodies",
          "Bartonella_Serology",
          "TB_Screen",
          "HIV_Test",
          "CSF_Cytology",
          "AQP4_Antibodies"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 2,
        "primary_tests_missed_count": 1,
        "primary_tests_coverage_percentage": 0.6666666666666666,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 8,
        "ddx_tests_coverage_percentage": 0.5
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 161).\n\n- Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 161).\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High dose corticosteroid therapy for presumed giant cell arteritis (for example intravenous methylprednisolone 500\u20131000 mg daily for 3 days followed by high dose oral prednisolone)",
            "timing": "Start Now",
            "reasons": [
              "Age over 50 with acute unilateral visual loss and relative afferent pupillary defect strongly suggests arteritic anterior ischaemic optic neuropathy",
              "Raised inflammatory markers markedly increase the pre test probability of giant cell arteritis",
              "Delay in steroid treatment significantly increases the risk of permanent bilateral blindness",
              "Temporal artery biopsy and imaging remain interpretable if performed within 1\u20132 weeks after starting steroids"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastrointestinal protection during high dose steroid therapy",
            "timing": "Start Now",
            "reasons": [
              "High dose systemic steroids increase the risk of peptic ulcer disease and upper gastrointestinal bleeding",
              "Concurrent gastroprotection reduces avoidable steroid related gastrointestinal complications",
              "Patient is likely to require a prolonged steroid taper"
            ]
          },
          {
            "treatment": "Low dose aspirin 75\u2013100 mg daily",
            "timing": "Start Now",
            "reasons": [
              "Often recommended in giant cell arteritis to reduce further cranial ischaemic events when not contraindicated",
              "May provide additional vascular protection if the final diagnosis is an ischaemic optic neuropathy or retinal vascular occlusion",
              "Bleeding risk can be mitigated with gastroprotection and assessment of contraindications"
            ]
          },
          {
            "treatment": "Calcium and vitamin D supplementation",
            "timing": "Delay",
            "reasons": [
              "Indicated to prevent steroid induced osteoporosis when prolonged corticosteroid therapy is confirmed",
              "Can be initiated after baseline calcium and vitamin D levels and bone health assessment"
            ]
          },
          {
            "treatment": "Bisphosphonate therapy such as oral alendronate",
            "timing": "Delay",
            "reasons": [
              "Recommended for patients commencing long term high dose steroids who are at increased fracture risk",
              "Should follow fracture risk stratification and, ideally, dental review to minimise risk of osteonecrosis of the jaw"
            ]
          },
          {
            "treatment": "Disease modifying therapy for multiple sclerosis if demyelinating optic neuritis is confirmed",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of multiple sclerosis with MRI and clinical criteria before initiation",
              "Choice of agent must be individualised and started in a specialist neuroimmunology service"
            ]
          },
          {
            "treatment": "Aggressive vascular risk factor modification including antihypertensive therapy, statin therapy, and smoking cessation support",
            "timing": "Delay",
            "reasons": [
              "Important for long term secondary prevention if an ischaemic optic neuropathy or retinal vascular event is confirmed",
              "Implementation should follow comprehensive cardiovascular risk assessment and coordination with primary care"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High dose corticosteroid therapy for presumed giant cell arteritis (for example intravenous methylprednisolone 500\u20131000 mg daily for 3 days followed by high dose oral prednisolone)",
            "timing": "Start Now",
            "reasons": [
              "Age over 50 with acute unilateral visual loss and relative afferent pupillary defect strongly suggests arteritic anterior ischaemic optic neuropathy",
              "Raised inflammatory markers markedly increase the pre test probability of giant cell arteritis",
              "Delay in steroid treatment significantly increases the risk of permanent bilateral blindness",
              "Temporal artery biopsy and imaging remain interpretable if performed within 1\u20132 weeks after starting steroids"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CRP: 161)."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 161).\n\n- Timing of current symptoms not specified, so no indication whether this is a new relapse or an old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease modifying therapy for multiple sclerosis if demyelinating optic neuritis is confirmed",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of multiple sclerosis with MRI and clinical criteria before initiation",
              "Choice of agent must be individualised and started in a specialist neuroimmunology service"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (CRP: 161)."
              ]
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (CRP: 161).\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 3,
          "reasons_acknowledged": 0,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 1,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.3333333333333333
        }
      }
    }
  }
}